MarketsandMarkets Presenting The 5th Annual Biomarker and Companion Diagnostics Conference in San Diego, USA is scheduled on February 6th and 7th, 2020. Hurry! Limited Seats Available for the Conference in San Diego USA.

A biomarker is a quantifiable indicator of a biological state or condition of humans and animals. Biomarkers are measured and evaluated to examine normal biological, pathogenic, or pharmacologic responses to a therapeutic condition. The use of biomarkers in basic and clinical research are common nowadays. Biomarkers provide a dynamic and effective approach to understand the range of neurological disease. A ‘companion diagnostic’ is a test for a predictive biomarker, that classifies patients into responders and non-responders, for a particular therapeutic medium.

Designed to deliver a progressive approach to the scope and challenges affecting market growth for the biomarker industry, the 5th Annual MarketsandMarkets Biomarker and Companion Diagnostics Conference in San Diego, USA will concentrate on Biomarker Discovery, Exploratory Biomarkers and application of biomarkers in Immuno-oncology, neurology and inflammatory diseases.The event is scheduled to be held on February 6th and 7th, 2020.

Key Highlights of this Event:

  • More than 30 experts from academic institutes and industry will be bestowing their present project in Biomarker.
  • Up-to-date information on regulatory strategies and approvals, Cancer biomarker authentication for clinical application, Biomarkers and Personalized Medication, Impact of Big data in translational biomarker research and Future of Companion Diagnostics will be discussed.

Why you need to attend this event?

  • This Biomarker and Companion Diagnostics Conference will provide an opportunity to develop stable business associations and networking opportunities with scientists, clinicians, researchers, educators and professionals from pharmaceutical and bio-pharma companies, universities, and research institutes.
  • Over 20 demonstrations, round-tables, and panel discussions centred on the prime prospects and challenges in biomarker research, from precision medicine and companion diagnostics to digital biomarkers and clinical trials will be arranged.
  • This Biomarker Diagnostics Conference will open an avenue for the industry stakeholders to get introduced by latest updates on the field of Biomarker and Companion Diagnostics Research
  • The attendees will receive Congress Workbook and Delegate Kit for Both Days, Access to the Exhibition Area and Networking Sessions, Discounted Price for Poster Presentation, Lifetime Access to Presentation Slides, Certificate of Participation and Refreshments and Luncheons.

Download an Agenda of Biomarker and Companion Diagnostics Conference @


  • Steven Richards Investigator, Biomarker Expert Novartis
  • Pallavi Sachdev Senior Director, Clinical Pharmacology and Translational Medicine Eisai
  • Howard Federoff Professor of Neurology University of California
  • Shailendra Singh (Shelly) Chief Operating Officer MarketsandMarkets
  • Mark Ma Executive Director, Bioanalytical and Biomarker Development Alexion Pharmaceuticals
  • John Rossi Director, Translational Sciences Kite Pharma
  • Kristin Blouch Associate Director, Clinical Biomarker Lead, GSK
  • Martine Roudier Head Pathologist, TransPathology Lab AstraZeneca
  • Amber Donahue Biomarker Assay Specialist Pfizer
  • Yisrael Katz Director of Clinical Applications Calviri Inc.
  • Naveen Babbar Executive Director, Precision Medicine Leader Novartis
  • Elizabeth Somers Director, Diagnostic Development Eisai
  • Vicky Wu Co-Investigator Fred Hutch
  • Hua Fang Clinical Biomarker Lead AbbVie
  • Senior Representative Imagia
  • Senior Representative Celgene


  • Invivoscribe
  • Myriad RBM
  • Imagia
  • Paragon Genomics
  • Dermtech
  • Sengenics
  • IDDI
  • Flagship Biosciences
  • Eutropics
  • HTG
  • Proteome Sciences

Who Should attend this event?

The prime stakeholders who will be benefitted by attending this event are:

  • Academic Delegates
  • Solution Provider Delegate
  • Pharma/Biotech Delegates

This two-day Biomarker Diagnostics Conference and Companion Diagnostics Conference arranged by MarketsandMarkets will invite 100+ biomarker discovery professionals, 20+ expert speakers and 15+ solution/technology providers to an exclusive platform to deliver important buyer-seller ecosystem in the biomarker Industry.

Date of Event: February 6th and 7th, 2020.

Event Address: 1380 Harbor Island Dr, Sheraton San Diego Hotel and Marina, CA 92101, United States.

Hurry! Book Tickets Now! Solution Provider Delegate $1499 @

Press Release Distributed by The Express Wire

To view the original version on The Express Wire visit Book Your Tickets For Biomarker and Companion Diagnostics Conference in San Diego